Form EFFECT Niagen Bioscience, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 9, 2026 4:05 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Niagen Bioscience: Study links CD38 enzyme to NAD+ decline in aging placental tissue
- Miquido Releases AI Reality Check eBook on How to Build AI Products Users Trust and Adopt
- Maris-Tech Receives Record US$10 Million Order - Its Largest-Ever Contract - for Advanced Video Systems on Next-Generation Airborne Defense Platforms
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
